Lawrence D. Garber, MD

Articles by Lawrence D. Garber, MD

Quality Measurement of Medication Monitoring in the Meaningful Use Era

ByJennifer Tjia, MD, MSCE,Terry S. Field, DSc,Shira H. Fischer, AB,Shawn J. Gagne, BA,Daniel J. Peterson, MA, MS,Lawrence D. Garber, MD,Jerry H. Gurwitz, MD

September 7th 2011

Shifting from claims to integrated electronic health records to calculate quality metrics will improve reported quality attributable to data capture changes, not true quality improvements.

Development and Pilot Testing of Guidelines to Monitor High-Risk Medications in the Ambulatory Setting

ByJennifer Tjia, MD, MSCE,Terry S. Field, DSc,Lawrence D. Garber, MD,Jennifer L. Donovan, PharmD,Abir O. Kanaan, PharmD,Marsha A. Raebel, PharmD,Yanfang Zhao, MA,Jacquelyne C. Fuller, MPH,Shawn J. Gagne, BA,Shira H. Fischer, AB,Jerry H. Gurwitz, MD

July 17th 2010

Pilot testing of guidelines for the laboratory monitoring of high-risk medications shows that monitoring is highly variable and that there is room for improvement.

Latest Updated Articles

Development and Pilot Testing of Guidelines to Monitor High-Risk Medications in the Ambulatory Setting
July 17th 2010
Quality Measurement of Medication Monitoring in the Meaningful Use Era
September 7th 2011

Lawrence D. Garber, MD

Articles by Lawrence D. Garber, MD

Quality Measurement of Medication Monitoring in the Meaningful Use Era

Development and Pilot Testing of Guidelines to Monitor High-Risk Medications in the Ambulatory Setting

Latest Updated Articles

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access